News
Academy
Editorial PodcastsEditorial VideosProfiles in Medicine
Conference CoverageConference Listing
Pharmaceutical Executive
Partner Perspectives
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Subscribe
Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
Spotlight -
  • Pharmaceutical Executive APEX Awards
  • Latest Executive Roundtables
  • Asembia 2025
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

Corporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate CommunicationsCorporate Communications
Direct-to-ConsumerDirect-to-ConsumerDirect-to-ConsumerDirect-to-Consumer
Emerging BiopharmaEmerging BiopharmaEmerging Biopharma
IR Licensing and PartnershipsIR Licensing and PartnershipsIR Licensing and Partnerships
Market AccessMarket AccessMarket AccessMarket Access
Medical AffairsMedical AffairsMedical AffairsMedical Affairs
OperationsOperationsOperationsOperationsOperations
Patient EngagementPatient Engagement
RegulatoryRegulatoryRegulatoryRegulatory
Sales & MarketingSales & MarketingSales & MarketingSales & MarketingSales & Marketing
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Academy
    • Partner Perspectives
    • Subscribe
Advertisement

Industry Trends

>
  • IR Licensing and Partnerships

Latest News

Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
Novo Nordisk CEO Lars Fruergaard Jørgensen to Step Down Amid Strategic Leadership Transition
By Don Tracy, Associate Editor

May 16th 2025

Jørgensen will step down after eight years as CEO, with a successor search underway while the company reaffirms confidence in its strategic plans amid recent market challenges.

Earned Media and ASCO: Provide Context Beyond the Data
Earned Media and ASCO: Provide Context Beyond the Data
By Michael Christel

May 13th 2025

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.

GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
GLP-1 Surge Fuels 10.2% Rise in US Prescription Drug Spending in 2024, ASHP Reports
By Don Tracy, Associate Editor

May 13th 2025

Weight-loss and diabetes drugs dominated pharmaceutical spending last year, according to a new report by the American Society of Health-System Pharmacists, who warns of tariff-driven supply chain threats and continued growth in clinic drug costs.

Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
Thermo Fisher to Invest $2 Billion in US Biotech Manufacturing, R&D
By Don Tracy, Associate Editor

April 28th 2025

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on high-impact innovations.

Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation
By Don Tracy, Associate Editor

April 22nd 2025

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics production, gene therapy capabilities, and next generation R&D centers.

More News


Pamela Walker, Ph.D., and Jen Nixon

What Pharma Can Learn From the Consumer Market When It Comes to ESG

Pamela Walker, Ph.D;Jen Nixon
August 11th 2022

The pharma industry is beginning to perform better with environmental, social, and governance (ESG).


Site Logo

Pharma’s Training Transformation: COVID Forces Compliance Revamp, Re-education

Mike Hollan
August 10th 2022

How one company in particular has adjusted its internal and customer-facing strategies in compliance training amid today’s heightened business-risk climate.


The Potential of Proteomics

The Potential of Proteomics

Claire Wallace
August 10th 2022

Major stakeholders—including policymakers, public-private interests, and academia—are increasingly embracing the potential of proteomics technology in reshaping diagnostics and patient care.


Haydn Boehm

Embracing the Renaissance of Small Molecule Drug Discovery

Haydn Boehm
August 4th 2022

Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.


USSF co-founders Dr. Kyle Flanigan, Ph.D. and Dr. Garry Morefield, Ph.D.

Q&A with Dr. Kyle Flanigan, Ph.D., Co-Founder and CEO of USSF

Pharmaceutical Executive Editorial Staff
August 3rd 2022

Dr. Kyle Flanigan, Ph.D., discusses the benefits of an oral COVID-19 vaccine.


Jim Corrigan, CEO ConnectiveRX

Q&A With ConnectiveRx CEO Jim Corrigan

July 27th 2022

Corrigan discusses the importance of a patient-centric approach.


Policy Reforms for Orphan Drugs

Policy Reforms for Orphan Drugs

Jack Mycka
July 20th 2022

Outlook for orphan PRMA environment in the US, EU4, and UK.


It’s Time to Invest in Reproductive Medicine and Maternal Health

It’s Time to Invest in Reproductive Medicine and Maternal Health

Araz Raoof
July 7th 2022

Amidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.


Q&A With Chris Round, president, EMD Serono

Q&A With Chris Round, president, EMD Serono

July 6th 2022

Round discusses how he adjusted his leadership style and approach to patient care in the most effective way during the pandemic.


Q&A With Natalie DiMambro, vice president, product commercialization and training at Within3

Q&A With Natalie DiMambro, vice president, product commercialization and training at Within3

June 29th 2022

DiMambro discusses how companies can update their systems and strategies to collect data which ensures that marginalized groups and diverse voices are included.


Q&A With Paul Ford, co-founder and president, DS9 Capital

Q&A With Paul Ford, co-founder and president, DS9 Capital

June 17th 2022

Ford discusses how rising drug costs in impact patients, and how they can either avoid them or find less-expensive options.


Orphan Drugs: From Niche to Mainstream

Orphan Drugs: From Niche to Mainstream

Melanie Senior
June 15th 2022

Larger pipeline and increased support from regulatory authorities are setting up the orphan drug market for long-term success.


Why Are We Surrendering to COVID?

Why Are We Surrendering to COVID?

Seth Lederman, MD
June 14th 2022

Industry must continue research and development to combat the pandemic.


Q&A With Matt Flesch, vice president of communications and patient advocacy, Horizon Therapeutics

Q&A With Matt Flesch, vice president of communications and patient advocacy, Horizon Therapeutics

June 7th 2022

Flesch speaks with Pharm Exec about his work to bring a patient-centric approach to the forefront of the industry.


A New Era in European Life Sciences Investment

A New Era in European Life Sciences Investment

Jack O’Meara
June 6th 2022

Investments setting up sector for future success that could one day rival its US counterpart.


The Agile Future of Medical Information: Meeting 21st-Century Demands for Healthcare

The Agile Future of Medical Information: Meeting 21st-Century Demands for Healthcare

Alisa Hummings;Simon Johns
June 3rd 2022

COVID-19 pandemic has accelerated raised expectations for medical information professionals.


Q&A With Michael Moorman, principal at ZS Associates

Q&A With Michael Moorman, principal at ZS Associates

June 2nd 2022

Moorman discusses critical aspects of key account management in pharma.


Site Logo

IQVIA Releases Global Oncology Trend Report for 2022

Mike Hollan
May 26th 2022

While patients continue to benefit from increased product launches, the pandemic is still having an impact on caseload.


Q&A With Javier Szwarcberg, MD, MPH, CEO of Spruce Biosciences

Q&A With Javier Szwarcberg, MD, MPH, CEO of Spruce Biosciences

May 26th 2022

Szwarcberg discusses challenges in the rare disease drug development space, and how his background is helping him find solutions for patients, specifically with endocrine disorders.


Partnering to Respond to a Possible Nuclear Threat

Partnering to Respond to a Possible Nuclear Threat

Steve Scalia;Bob Mulroy;John L. McManus
May 25th 2022

Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.


Sustaining Pace With Contingent Workers

Sustaining Pace With Contingent Workers

Autumn Vaupel
May 24th 2022

Pandemic workforce trends continue to create challenges for pharma.


Three Key Steps to Unlocking mRNA’s Potential Beyond COVID-19

Three Key Steps to Unlocking mRNA’s Potential Beyond COVID-19

Sadik Kassim
May 24th 2022

Improvements in R&D, manufacturing, and data sharing will extend platform’s reach.


Aligning Contracting to Solve for Payer Risks Is a Win for Biopharma, Payers, and Patients

Aligning Contracting to Solve for Payer Risks Is a Win for Biopharma, Payers, and Patients

Jane F. Barlow;Mark Trusheim
May 11th 2022

Upcoming regulatory changes to create new opportunity for specialized offerings.


What the COVID-19 Vaccine Process Showed Us, and How It Can Impact the Future of Drug Development

What the COVID-19 Vaccine Process Showed Us, and How It Can Impact the Future of Drug Development

Marc Helberg
May 10th 2022

Industry has shown it can overcome challenges en route to creating new therapies.


Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements

Why Pharmaceutical Manufacturers Must Navigate Muddy Waters of ESG Requirements

Rashida Salahuddin
May 3rd 2022

Rise in demand for sustainable practices forces industry to be more proactive.


Q&A With Harvard Business School Professor Linda A. Hill

Q&A With Harvard Business School Professor Linda A. Hill

Michael Wong
May 3rd 2022

Hill shares her insights on what is needed for a turnaround in talent development.


If Content Is King, Context Is the Power Behind the Throne

If Content Is King, Context Is the Power Behind the Throne

Chris Bryant
May 3rd 2022

New mediums of technology must be utilized correctly to reap full benefits.


Biopharma and ESG: Key Strategies for Companies, Meaningful Changes to Communities

Biopharma and ESG: Key Strategies for Companies, Meaningful Changes to Communities

Adam Lohr
April 21st 2022

New regulations set stage for updated ESG considerations.


The Role and Recruitment of the Chief Patient Officer

The Role and Recruitment of the Chief Patient Officer

Stephen Brengle
April 21st 2022

New C-Suite position emerges for more emphasis on patient centricity.


Q&A With Miruna Sasu, president and CEO, COTA, Inc.

Q&A With Miruna Sasu, president and CEO, COTA, Inc.

April 20th 2022

From exposing disparities in care to guiding better patient outcomes to helping reign in the costs of care, the use of real-world data (RWD) in oncology can have far-reaching effects. Here’s how one RWD company exec is using her experience to help drive that change.

<1
...
34567891011
...
19>
About
Advertise
Contact Us
Editorial Board
Editorial Submission Guidelines
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.